205 related articles for article (PubMed ID: 29430839)
1. Effects of l-Carnosine Supplementation on Sleep Disorders and Disease Severity in Autistic Children: A Randomized, Controlled Clinical Trial.
Mehrazad-Saber Z; Kheirouri S; Noorazar SG
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):72-77. PubMed ID: 29430839
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.
Chez MG; Buchanan CP; Aimonovitch MC; Becker M; Schaefer K; Black C; Komen J
J Child Neurol; 2002 Nov; 17(11):833-7. PubMed ID: 12585724
[TBL] [Abstract][Full Text] [Related]
3. Carnosine supplementation does not affect serum concentrations of advanced glycation and precursors of lipoxidation end products in autism: a randomized controlled clinical trial.
Ghodsi R; Kheirouri S; Nosrati R
Ann Clin Biochem; 2019 Jan; 56(1):148-154. PubMed ID: 30089410
[TBL] [Abstract][Full Text] [Related]
4. Effect of L-Carnosine in children with autism spectrum disorders: a systematic review and meta-analysis of randomised controlled trials.
Abraham DA; Undela K; Narasimhan U; Rajanandh MG
Amino Acids; 2021 Apr; 53(4):575-585. PubMed ID: 33704575
[TBL] [Abstract][Full Text] [Related]
5. Children with autism: effect of iron supplementation on sleep and ferritin.
Dosman CF; Brian JA; Drmic IE; Senthilselvan A; Harford MM; Smith RW; Sharieff W; Zlotkin SH; Moldofsky H; Roberts SW
Pediatr Neurol; 2007 Mar; 36(3):152-8. PubMed ID: 17352947
[TBL] [Abstract][Full Text] [Related]
6. Effect of L-Carnosine as adjunctive therapy in the management of children with autism spectrum disorder: a randomized controlled study.
Ann Abraham D; Narasimhan U; Christy S; Muhasaparur Ganesan R
Amino Acids; 2020 Dec; 52(11-12):1521-1528. PubMed ID: 33170378
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in autism.
McGinnis WR
Altern Ther Health Med; 2004; 10(6):22-36; quiz 37, 92. PubMed ID: 15624347
[TBL] [Abstract][Full Text] [Related]
8. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.
Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD
J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248
[TBL] [Abstract][Full Text] [Related]
11. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
Ghaleiha A; Ghyasvand M; Mohammadi MR; Farokhnia M; Yadegari N; Tabrizi M; Hajiaghaee R; Yekehtaz H; Akhondzadeh S
J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
[TBL] [Abstract][Full Text] [Related]
12. Carnosine treatment for gulf war illness: a randomized controlled trial.
Baraniuk JN; El-Amin S; Corey R; Rayhan R; Timbol C
Glob J Health Sci; 2013 Feb; 5(3):69-81. PubMed ID: 23618477
[TBL] [Abstract][Full Text] [Related]
13. A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia.
Chengappa KN; Turkin SR; DeSanti S; Bowie CR; Brar JS; Schlicht PJ; Murphy SL; Hetrick ML; Bilder R; Fleet D
Schizophr Res; 2012 Dec; 142(1-3):145-52. PubMed ID: 23099060
[TBL] [Abstract][Full Text] [Related]
14. Carnosine pretreatment protects against hypoxia-ischemia brain damage in the neonatal rat model.
Zhang X; Song L; Cheng X; Yang Y; Luan B; Jia L; Xu F; Zhang Z
Eur J Pharmacol; 2011 Sep; 667(1-3):202-7. PubMed ID: 21693116
[TBL] [Abstract][Full Text] [Related]
15. Risperidone in children with autism: randomized, placebo-controlled, double-blind study.
Nagaraj R; Singhi P; Malhi P
J Child Neurol; 2006 Jun; 21(6):450-5. PubMed ID: 16948927
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
[TBL] [Abstract][Full Text] [Related]
17. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of the carnosine - α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease.
Kulikova OI; Berezhnoy DS; Stvolinsky SL; Lopachev AV; Orlova VS; Fedorova TN
Regul Toxicol Pharmacol; 2018 Jun; 95():254-259. PubMed ID: 29601911
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems.
Garstang J; Wallis M
Child Care Health Dev; 2006 Sep; 32(5):585-9. PubMed ID: 16919138
[TBL] [Abstract][Full Text] [Related]
20. Dietary docosahexaenoic acid supplementation in children with autism.
Voigt RG; Mellon MW; Katusic SK; Weaver AL; Matern D; Mellon B; Jensen CL; Barbaresi WJ
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):715-22. PubMed ID: 24345834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
